Erasmus Partnership Part of Ingenuity's 'Significant Investment' in NGS Data Analysis

The hospital will use Ingenuity Pathway Analysis and the Ingenuity Knowledgebase to support its cancer research projects. The partnership is part of a "significant investment in the enabling of next-generation sequencing analysis" at Ingenuity, a company spokesperson said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.